RESUMEN
OBJECTIVES: This study aimed to assess the impact of the COVID-19 pandemic on national surveillance of viral hepatitis in Italy. STUDY DESIGN: Interrupted time series analysis. METHODS: Using an interrupted time series analysis with a customised AutoRegressive Integrated Moving Average model on hepatitis cases reported to the Integrated Epidemiological System of Acute Viral Hepatitis from 2006 to 2022, we examined trends in incidence, time to diagnosis and time to epidemiological investigations for hepatitis A, hepatitis B and hepatitis C. RESULTS: The quarterly incidence of hepatitis B (-0.251, P = 0.05) and hepatitis C (-0.243, P = 0.003) significantly decreased with the onset of the pandemic. Surveillance times for hepatitis B (5.496, P < 0.001) and hepatitis C (35.723, P < 0.001), measured as days lost per quarter, significantly increased 12 and 24 months after the pandemic's start. This aligns with a notable rise in quarterly incidence at 36 months for both (0.032, P = 0.030 for hepatitis B; 0.040, P < 0.001 for hepatitis C). CONCLUSIONS: The decrease in reported cases could be due to an increase in infection prevention control and containment measures put in place in a pandemic context. However, a delay in the initiation of epidemiological investigations was observed, which could lead to a further increase in incidence in the future.
Asunto(s)
COVID-19 , Hepatitis C , Análisis de Series de Tiempo Interrumpido , Humanos , Italia/epidemiología , COVID-19/epidemiología , Incidencia , Hepatitis C/epidemiología , SARS-CoV-2 , Hepatitis B/epidemiología , Pandemias , Hepatitis Viral Humana/epidemiologíaRESUMEN
PURPOSE: To investigate associations between enzyme activity of glutathione reductase (GR) with and without added flavin adenine dinucleotide (FAD), glutathione peroxidase (GPX), and 6-phosphogluconic dehydrogenase (6PGDH) in the lens epithelium collected at surgery, and some nutritional and biochemical variables determined in the same individuals during the Italian-American Case-Control Study of age-related cataract. METHODS: One hundred eighty-three epithelium capsule samples were collected from 174 patients undergoing surgery. Data on enzyme activity were obtained from 52 samples for 6-PGDH and from 53 samples for GR and for GPX. The Lens Opacity Classification System II was used to classify and grade cataracts. RESULTS: No correlation was found between enzyme activity in lens epithelium and the same enzymatic activity in erythrocytes (with the exception of a negative correlation between lens and erythrocyte 6PGDH activity), or the type and severity of cataract. No correlation was found between lens GPX activity and plasma selenium and between lens GR activation coefficient (GRAC) and riboflavin intake. Lens GR with added FAD and lens GRAC were significantly correlated to plasma vitamin E level. Lens GRAC was positively correlated to a nutritional vitamin index. CONCLUSIONS: Present data stress the difficulty in verifying the assumption that biochemical indices collected on plasma and on erythrocyte actually reflect the status of these factors in the lens itself.
Asunto(s)
Catarata/enzimología , Cápsula del Cristalino/enzimología , Anciano , Estudios de Casos y Controles , Extracción de Catarata , Epitelio/enzimología , Eritrocitos/enzimología , Glutatión Peroxidasa/metabolismo , Glutatión Reductasa/metabolismo , Humanos , Fosfogluconato Deshidrogenasa/metabolismo , Riboflavina/metabolismo , Selenio/sangre , Vitamina E/sangreRESUMEN
In 1990, the prevalence of antibodies to hepatitis A virus infection (anti-HAV) was assayed by the ELISA method on a national sample of 1000 recruits aged 18-24 years. The overall prevalence was 29.4% (22.4% in the northern and central regions, 32.2% in the south and islands; p < 0.01). Compared with a similar study conducted in 1981, the results show a marked reduction in anti-HAV prevalence (from 66.3% to 29.4%; p < 0.01). These findings reflect the improved sanitation standards in Italy and indicate that the proportion of non-immune adults is increasing, with a higher risk of symptomatic infection in the near future.